15 reports

This transaction will enable Trek Therapeutics to broaden its antiviral portfolio and further develop antiviral drugs that are affordable and accessible.

  • Cystic Fibrosis
  • United States
  • Company
  • Company Operations
  • Vertex Pharmaceuticals Incorporated

The current products for IPF have generated global revenues in excess of $## billion in 2016.

  • Cystic Fibrosis
  • Healthcare
  • Pharmaceutical
  • Australia
  • Pharmaxis Ltd

Its proprietary redox switch is employed to generate novel antiviral and antibacterial drugs in the region of infectious disease.

  • Cystic Fibrosis
  • Therapy
  • United States
  • Company
  • Product Initiative

The prominent features of this report are - ##.

  • Cancer Hormonal Therapy
  • Clinical Trial
  • Drug Development
  • World
  • Product Initiative

Drivers and their Impact Customer Category 2014 Drivers and their Impact on Cystic Fibrosis Market in Europe by Key Driver Unmet Medical Needs Increased Prevalence of Cystic Fibrosis Patient Assistance Programs Presence of Diagnostic Procedures ## ## ## ## ## Low Low ## ## ## ## ## Low Low

  • Cystic Fibrosis
  • Actavis plc
  • F. Hoffmann-La Roche Ltd.
  • Gilead Sciences, Inc.
  • Novartis AG

It offers products in the therapeutic areas of oncology, hematology, immune diseases, antibiotics, antivirals, neurology, cardiology, multiple sclerosis, hemophilia and diabetes, among others.

  • Cancer Hormonal Therapy
  • Endocrine Disease
  • United States
  • Product Initiative
  • Alnylam Pharmaceuticals, Inc.

It offers products in the therapeutic areas of oncology, hematology, immune diseases, antibiotics, antivirals, neurology, cardiology, multiple sclerosis, hemophilia and diabetes, among others.

  • Cancer Hormonal Therapy
  • Endocrine Disease
  • Monoclonal Antibody
  • Therapy
  • Alnylam Pharmaceuticals, Inc.

The trial will be a randomized (##:##), placebo-controlled, double-blind study.

  • Cancer Hormonal Therapy
  • Hepatitis
  • World
  • Product Initiative
  • Pfizer Inc.

Exportin ## (Chromosome Region Maintenance ## Protein Homolog or XPO##) - Overview EXPORTIN ## (XPO##) OR CHROMOSOMAL MAINTENANCE ## (CRM##) IS A EUKARYOTIC PROTEIN.

  • Cancer
  • Cancer Hormonal Therapy
  • United States
  • Product Initiative
  • Karyopharm Therapeutics Inc.

Partner ## Partner ## Deal status PTC Therapeutics, Inc.

  • Cardiology
  • Cystic Fibrosis
  • Healthcare
  • Therapy
  • PTC Therapeutics, Inc.

Partner ## Partner ## Deal status PTC Therapeutics, Inc.

  • Cardiology
  • Cystic Fibrosis
  • Healthcare
  • Therapy
  • PTC Therapeutics, Inc.

CLINICAL TRIAL PROFILE SNAPSHOTS Note: ##.

  • Blood Disease
  • Cancer Hormonal Therapy
  • Clinical Trial
  • Targeted Therapy
  • World
  • CYSTIC FIBROSIS - PIPELINE BY CYCLACEL PHARMACEUTICALS INC, H1 2018
  • CYSTIC FIBROSIS - PIPELINE BY CYCLENIUM PHARMA INC, H1 2018

It provides preclinical pipeline such as antiviral and oncology targets, multiple oncology targets, antiviral targets, antibacterial and antifungal targets and target against pain.

  • Cancer Hormonal Therapy
  • Cystic Fibrosis
  • Therapy
  • United States
  • Galapagos NV

In the study, no antagonistic effects on the antiviral activity were observed when INCIVEK was used in combination with amprenavir, darunavir, and lopinavir, and slight antagonistic effects were observed on the antiviral activity of atazanavir.

  • Cystic Fibrosis
  • Pharmaceutical
  • United States
  • Company Operations
  • Vertex Pharmaceuticals Incorporated

In January 2009, the alliance in antibacterials and antivirals was expanded to include three more discovery targets.

  • Cystic Fibrosis
  • Therapy
  • World
  • Product Initiative
  • Galapagos NV